B-cell lymphoma 6 promotes proliferation and survival of trophoblastic cells

References

• Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009; 30 Suppl (A): S32-7; PMID:19070896; http://dx.doi.org/10.1016/j.placenta.2008.11.009
   PubMedGoogle Scholar
• Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta. 2009; 30 Suppl (A): S38-S42; PMID:19138798; http://dx.doi.org/10.1016/j.placenta.2008.11.021
   PubMedGoogle Scholar
• Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008; 51(4): 970-5; PMID:18259009; http://dx.doi.org/10.1161/HYPERTENSIONAHA.107.107607
   PubMed Web of Science ®Google Scholar
• Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009; 33(3): 130-7; PMID:19464502; http://dx.doi.org/10.1053/j.semperi.2009.02.010
   PubMed Web of Science ®Google Scholar
• Louwen F, Muschol-Steinmetz C, Reinhard J, Reitter A, Yuan J. A lesson for cancer research: placental microarray gene analysis in preeclampsia. Oncotarget. 2012; 3(8): 759-73; PMID:22929622; http://dx.doi.org/10.18632/oncotarget.595
   PubMed Web of Science ®Google Scholar
• Louwen F, Muschol-Steinmetz C, Friemel A, Kampf AK, Tottel E, Reinhard J, Yuan J. Targeted gene analysis: increased B-cell lymphoma 6 in preeclamptic placentas. Hum Pathol. 2014; 45(6): 1234-42; PMID:24767250; http://dx.doi.org/10.1016/j.humpath.2014.02.002
   PubMed Web of Science ®Google Scholar
• Muschol-Steinmetz C, Friemel A, Kreis NN, Reinhard J, Yuan J, Louwen F. Function of survivin in trophoblastic cells of the placenta. PLoS One. 2013; 8(9): e73337; PMID:24069188; http://dx.doi.org/10.1371/journal.pone.0073337
   PubMed Web of Science ®Google Scholar
• Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity. 2000; 13(2): 199-212; PMID:10981963; http://dx.doi.org/10.1016/S1074-7613(00)00020-0
   PubMed Web of Science ®Google Scholar
• Basso K, Dalla-Favera R. Roles of BCL6 in normal and transformed germinal center B cells. Immunol Rev. 2012; 247(1): 172-83; PMID:22500840; http://dx.doi.org/10.1111/j.1600-065X.2012.01112.x
   PubMed Web of Science ®Google Scholar
• Baron BW, Nucifora G, McCabe N, Espinosa R, III, Le Beau MM, McKeithan TW. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas. Proc Natl Acad Sci U S A. 1993; 90(11): 5262-6; PMID:8506375; http://dx.doi.org/10.1073/pnas.90.11.5262
   PubMed Web of Science ®Google Scholar
• Ye BH, Lista F, Lo CF, Knowles DM, Offit K, Chaganti RS, Dalla-Favera R. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science. 1993; 262(5134): 747-50; PMID:8235596; http://dx.doi.org/10.1126/science.8235596
   PubMed Web of Science ®Google Scholar
• Lemercier C, Brocard MP, Puvion-Dutilleul F, Kao HY, Albagli O, Khochbin S. Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor. J Biol Chem. 2002; 277(24): 22045-52; PMID:11929873; http://dx.doi.org/10.1074/jbc.M201736200
   PubMed Web of Science ®Google Scholar
• Wong CW, Privalsky ML. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6. J Biol Chem. 1998; 273(42): 27695-702; PMID:9765306; http://dx.doi.org/10.1074/jbc.273.42.27695
   PubMed Web of Science ®Google Scholar
• Ahmad KF, Melnick A, Lax S, Bouchard D, Liu J, Kiang CL, Mayer S, Takahashi S, Licht JD, Prive GG. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Mol Cell. 2003; 12(6): 1551-64; PMID:14690607; http://dx.doi.org/10.1016/S1097-2765(03)00454-4
   PubMed Web of Science ®Google Scholar
• Huynh KD, Bardwell VJ. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Oncogene. 1998; 17(19): 2473-84; PMID:9824158; http://dx.doi.org/10.1038/sj.onc.1202197
   PubMed Web of Science ®Google Scholar
• Dent AL, Vasanwala FH, Toney LM. Regulation of gene expression by the proto-oncogene BCL-6. Crit Rev Oncol Hematol. 2002; 41(1): 1-9; PMID:11796228; http://dx.doi.org/10.1016/S1040-8428(01)00164-0
   PubMed Web of Science ®Google Scholar
• Bajalica-Lagercrantz S, Piehl F, Farnebo F, Larsson C, Lagercrantz J. Expression of the BCL6 gene in the pre- and postnatal mouse. Biochem Biophys Res Commun. 1998; 247(2): 357-60; PMID:9642131; http://dx.doi.org/10.1006/bbrc.1998.8551
   PubMed Web of Science ®Google Scholar
• Logarajah S, Hunter P, Kraman M, Steele D, Lakhani S, Bobrow L, Venkitaraman A, Wagner S. BCL-6 is expressed in breast cancer and prevents mammary epithelial differentiation. Oncogene. 2003; 22(36): 5572-8; PMID:12944904; http://dx.doi.org/10.1038/sj.onc.1206689
   PubMed Web of Science ®Google Scholar
• Bos R, van Diest PJ, van der Groep P, Greijer AE, Hermsen MA, Heijnen I, Meijer GA, Baak JP, Pinedo HM, van der Wall E, et al. Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1alpha (HIF-1alpha). Oncogene. 2003; 22(55): 8948-51; PMID:14654791; http://dx.doi.org/10.1038/sj.onc.1206995
   PubMed Web of Science ®Google Scholar
• Walker SR, Liu S, Xiang M, Nicolais M, Hatzi K, Giannopoulou E, Elemento O, Cerchietti L, Melnick A, Frank DA. The transcriptional modulator BCL6 as a molecular target for breast cancer therapy. Oncogene. 2015; 34(9): 1073-82; PMID:24662818; http://dx.doi.org/10.1038/onc.2014.61
   PubMed Web of Science ®Google Scholar
• Winn VD, Gormley M, Paquet AC, Kjaer-Sorensen K, Kramer A, Rumer KK, Haimov-Kochman R, Yeh RF, Overgaard MT, Varki A, et al. Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology. 2009; 150(1): 452-62; PMID:18818296; http://dx.doi.org/10.1210/en.2008-0990
   PubMed Web of Science ®Google Scholar
• Nishizawa H, Ota S, Suzuki M, Kato T, Sekiya T, Kurahashi H, Udagawa Y. Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Reprod Biol Endocrinol. 2011; 9: 107; PMID:21810232; http://dx.doi.org/10.1186/1477-7827-9-107
   PubMed Web of Science ®Google Scholar
• Tsai S, Hardison NE, James AH, Motsinger-Reif AA, Bischoff SR, Thames BH, Piedrahita JA. Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathways. Placenta. 2011; 32(2): 175-82; PMID:21183218; http://dx.doi.org/10.1016/j.placenta.2010.11.014
   PubMed Web of Science ®Google Scholar
• Enquobahrie DA, Meller M, Rice K, Psaty BM, Siscovick DS, Williams MA. Differential placental gene expression in preeclampsia. Am J Obstet Gynecol. 2008; 199(5): 566-11; PMID:18533121; http://dx.doi.org/10.1016/j.ajog.2008.04.020
   PubMed Web of Science ®Google Scholar
• Trifonova EA, Gabidulina TV, Ershov NI, Serebrova VN, Vorozhishcheva AY, Stepanov VA. Analysis of the placental tissue transcriptome of normal and preeclampsia complicated pregnancies. Acta Naturae. 2014; 6(2): 71-83; PMID:25093114
   PubMed Web of Science ®Google Scholar
• Sitras V, Paulssen RH, Gronaas H, Leirvik J, Hanssen TA, Vartun A, Acharya G. Differential placental gene expression in severe preeclampsia. Placenta. 2009; 30(5): 424-33; PMID:19249095; http://dx.doi.org/10.1016/j.placenta.2009.01.012
   PubMed Web of Science ®Google Scholar
• Cerchietti LC, Ghetu AF, Zhu X, Da Silva GF, Zhong S, Matthews M, Bunting KL, Polo JM, Fares C, Arrowsmith CH, et al. A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo. Cancer Cell. 2010; 17(4): 400-11; PMID:20385364; http://dx.doi.org/10.1016/j.ccr.2009.12.050
   PubMed Web of Science ®Google Scholar
• Phan RT, Saito M, Basso K, Niu H, Dalla-Favera R. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat Immunol. 2005; 6(10): 1054-60; PMID:16142238; http://dx.doi.org/10.1038/ni1245
   PubMed Web of Science ®Google Scholar
• Phan RT, Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature. 2004; 432(7017): 635-9; PMID:15577913; http://dx.doi.org/10.1038/nature03147
   PubMed Web of Science ®Google Scholar
• Louwen F, Yuan J. Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy. Oncotarget. 2013; 4(7): 958-71; PMID:23948487; http://dx.doi.org/10.18632/oncotarget.1096
   PubMed Web of Science ®Google Scholar
• Carmena M, Wheelock M, Funabiki H, Earnshaw WC. The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis. Nat Rev Mol Cell Biol. 2012; 13(12): 789-803; PMID:23175282; http://dx.doi.org/10.1038/nrm3474
   PubMed Web of Science ®Google Scholar
• Sanhaji M, Kreis NN, Zimmer B, Berg T, Louwen F, Yuan J. p53 is not directly relevant to the response of Polo-like kinase 1 inhibitors. Cell Cycle. 2012; 11(3): 543-53; PMID:22262171; http://dx.doi.org/10.4161/cc.11.3.19076
   PubMed Web of Science ®Google Scholar
• Sanhaji M, Louwen F, Zimmer B, Kreis NN, Roth S, Yuan J. Polo-like kinase 1 inhibitors, mitotic stress and the tumor suppressor p53. Cell Cycle. 2013; 12(9): 1340-51; PMID:23574746; http://dx.doi.org/10.4161/cc.24573
   PubMed Web of Science ®Google Scholar
• Kreis NN, Sommer K, Sanhaji M, Kramer A, Matthess Y, Kaufmann M, Strebhardt K, Yuan J. Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21(WAF1/CIP1). Cell Cycle. 2009; 8(3): 460-472; PMID:19177004; http://dx.doi.org/10.4161/cc.8.3.7651
   PubMed Web of Science ®Google Scholar
• Kreis NN, Sanhaji M, Rieger MA, Louwen F, Yuan J. p21Waf1/Cip1 deficiency causes multiple mitotic defects in tumor cells. Oncogene. 2014; 33(50): 5716-28; PMID:24317508; http://dx.doi.org/10.1038/onc.2013.518
   PubMed Web of Science ®Google Scholar
• Kreis NN, Louwen F, Zimmer B, Yuan J. Loss of p21Cip1/CDKN1A renders cancer cells susceptible to Polo-like kinase 1 inhibition. Oncotarget. 2015; 6(9): 6611-26; PMID:25483104; http://dx.doi.org/10.18632/oncotarget.2844
   PubMed Web of Science ®Google Scholar
• Nigg EA, Stearns T. The centrosome cycle: Centriole biogenesis, duplication and inherent asymmetries. Nat Cell Biol. 2011; 13(10): 1154-60; PMID:21968988; http://dx.doi.org/10.1038/ncb2345
   PubMed Web of Science ®Google Scholar
• Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009; 30 Suppl (A): S32-7; PMID:19070896; http://dx.doi.org/10.1016/j.placenta.2008.11.009
   PubMedGoogle Scholar
• Kharfi AA, Leblanc S, Ouellet A, Moutquin JM. Dual action of H2O2 on placental hCG secretion: implications for oxidative stress in preeclampsia. Clin Biochem. 2007; 40(1–2): 94-7; PMID:17150203; http://dx.doi.org/10.1016/j.clinbiochem.2006.10.008
   PubMed Web of Science ®Google Scholar
• Basso K, Dalla-Favera R. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis. Adv Immunol. 2010; 105: 193-210; PMID:20510734; http://dx.doi.org/10.1016/S0065-2776(10)05007-8
   PubMed Web of Science ®Google Scholar
• Ranuncolo SM, Polo JM, Dierov J, Singer M, Kuo T, Greally J, Green R, Carroll M, Melnick A. Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. Nat Immunol. 2007; 8(7): 705-14; PMID:17558410; http://dx.doi.org/10.1038/ni1478
   PubMed Web of Science ®Google Scholar
• Redline RW, Patterson P. Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum Pathol. 1995; 26(6): 594-600; PMID:7774887; http://dx.doi.org/10.1016/0046-8177(95)90162-0
   PubMed Web of Science ®Google Scholar
• Jeschke U, Schiessl B, Mylonas I, Kunze S, Kuhn C, Schulze S, Friese K, Mayr D. Expression of the proliferation marker Ki-67 and of p53 tumor protein in trophoblastic tissue of preeclamptic, HELLP, and intrauterine growth-restricted pregnancies. Int J Gynecol Pathol. 2006; 25(4): 354-60; PMID:16990712; http://dx.doi.org/10.1097/01.pgp.0000225838.29127.6
   PubMed Web of Science ®Google Scholar
• Sharp AN, Heazell AE, Crocker IP, Mor G. Placental apoptosis in health and disease. Am J Reprod Immunol. 2010; 64(3): 159-69; PMID:20367628; http://dx.doi.org/10.1111/j.1600-0897.2010.00837.x
   PubMed Web of Science ®Google Scholar
• Hatzi K, Melnick A. Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis. Trends Mol Med. 2014; 20(6): 343-52; PMID:24698494; http://dx.doi.org/10.1016/j.molmed.2014.03.001
   PubMed Web of Science ®Google Scholar
• Ranuncolo SM, Polo JM, Melnick A. BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells. Blood Cells Mol Dis. 2008; 41(1): 95-9; PMID:18346918; http://dx.doi.org/10.1016/j.bcmd.2008.02.003
   PubMed Web of Science ®Google Scholar
• Lambrus BG, Uetake Y, Clutario KM, Daggubati V, Snyder M, Sluder G, Holland AJ. p53 protects against genome instability following centriole duplication failure. J Cell Biol. 2015; 210(1): 63-77; PMID:26150389; http://dx.doi.org/10.1083/jcb.201502089
   PubMed Web of Science ®Google Scholar
• Petsalaki E, Dandoulaki M, Morrice N, Zachos G. Chk1 protects against chromatin bridges by constitutively phosphorylating BLM serine 502 to inhibit BLM degradation. J Cell Sci. 2014; 127(Pt 18): 3902-8; PMID:25015292; http://dx.doi.org/10.1242/jcs.155176
   PubMed Web of Science ®Google Scholar
• Lawrence KS, Chau T, Engebrecht J. DNA damage response and spindle assembly checkpoint function throughout the cell cycle to ensure genomic integrity. PLoS Genet. 2015; 11(4): e1005150-; PMID:25898113; http://dx.doi.org/10.1371/journal.pgen.1005150
   PubMed Web of Science ®Google Scholar
• Graham CH. Effect of transforming growth factor-beta on the plasminogen activator system in cultured first trimester human cytotrophoblasts. Placenta. 1997; 18(2–3): 137-43; PMID:9089774; http://dx.doi.org/10.1016/S0143-4004(97)90085-0
   PubMed Web of Science ®Google Scholar
• Yuan J, Sanhaji M, Kramer A, Reindl W, Hofmann M, Kreis NN, Zimmer B, Berg T, Strebhardt K. Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo. Am J Pathol. 2011; 179(4): 2091-9; PMID:21839059; http://dx.doi.org/10.1016/j.ajpath.2011.06.031
   PubMed Web of Science ®Google Scholar
• Ritter A, Sanhaji M, Steinhauser K, Roth S, Louwen F, Yuan J. The activity regulation of the mitotic centromere-associated kinesin by Polo-like kinase 1. Oncotarget. 2015; 6(9): 6641-55; PMID:25504441; http://dx.doi.org/10.18632/oncotarget.2843
   PubMed Web of Science ®Google Scholar
• Sanhaji M, Kreis NN, Zimmer B, Berg T, Louwen F, Yuan J. p53 is not directly relevant to the response of Polo-like kinase 1 inhibitors. Cell Cycle. 2012; 11(3): 543-53; PMID:22262171; http://dx.doi.org/10.4161/cc.11.3.19076
   PubMed Web of Science ®Google Scholar
• Kreis NN, Sanhaji M, Kramer A, Sommer K, Rodel F, Strebhardt K, Yuan J. Restoration of the tumor suppressor p53 by downregulating cyclin B1 in human papillomavirus 16/18-infected cancer cells. Oncogene. 2010; 29(41): 5591-03; PMID:20661218; http://dx.doi.org/10.1038/onc.2010.290
   PubMed Web of Science ®Google Scholar
• Ritter A, Friemel A, Fornoff F, Adjan M, Solbach C, Yuan J, Louwen F. Characterization of adipose-derived stem cells from subcutaneous and visceral adipose tissues and their function in breast cancer cells. Oncotarget. 2015; 6(33): 34475-93; PMID:26439686
   PubMed Web of Science ®Google Scholar
• Ritter A, Sanhaji M, Friemel A, Roth S, Rolle U, Louwen F, Yuan J. Functional analysis of phosphorylation of the mitotic centromere-associated kinesin by Aurora B kinase in human tumor cells. Cell Cycle. 2015; 14(23):3755-67.
   PubMed Web of Science ®Google Scholar